Home › Compare › Semaglutide vs Retatrutide
Semaglutide vs Retatrutide
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
SemaglutideMetabolic / Weight Loss
RetatrutideMetabolic / Weight LossAt a glance
| Semaglutide | Retatrutide | |
|---|---|---|
| Category | Metabolic / Weight Loss | Metabolic / Weight Loss |
| Typical route | SubQ | SubQ |
| Shelf life once mixed | ~56 days | ~30 days |
| Commonly reported effects | Suppressed appetite Weight loss Better glucose control | Extreme fat loss Increased energy expenditure Metabolic reset |
| Reported considerations | Nausea Constipation Fatigue | Severe GI distress if titrated fast Elevated heart rate |
The differences that actually matter
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Once reconstituted, Semaglutide keeps noticeably longer than Retatrutide (~56 days vs ~30 days), so vial waste is a real difference between the two.
Where they overlap: weight loss.
Reported mainly for Semaglutide: suppressed appetite, better glucose control.
Reported mainly for Retatrutide: increased energy expenditure, metabolic reset.
What Semaglutide is
Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics the action of the naturally occurring incretin hormone GLP-1. Biochemically, it binds to and activates GLP-1 receptors located in various tissues, including the pancreas, brain, and gastrointestinal tract. In the pancreas, this activation promotes glucose-dependent insulin secretion and suppresses glucagon secretion, contributing to improved blood glucose regulation. In the brain, it influences satiety centers, leading to
What Retatrutide is
Retatrutide is an investigational peptide that operates as a triple agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. By activating these three distinct receptors, retatrutide is understood to influence multiple metabolic pathways, including glucose regulation, appetite control, and energy expenditure. The activation of GLP-1 and GIP receptors generally promotes glucose-dependent insulin secretion and slows gastric emptying, while glu
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — Semaglutide and Retatrutide are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between Semaglutide and Retatrutide?
Both are classed as Metabolic / Weight Loss peptides, so they get compared constantly and are often researched for overlapping reasons.
Can you log Semaglutide and Retatrutide in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, Semaglutide or Retatrutide?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.